6/7/2025Recent Executive Moves

6/6/2025Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...

6/6/2025Keymed Launches First-in-Human Trial of CM518D1

6/6/2025AstraZeneca's Imfinzi Approved in China for LS‑SCLC

6/6/2025BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia

6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...

6/5/2025NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Eval...

6/5/2025Cullinan Secures Global Rights to Genrix's Velinotamig

6/5/2025CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia

6/5/2025Mainland Chinese Market for Weight Loss and Diabetes Drugs to Soon Be ...

6/5/2025China Ascends to Global Leadership in Oncology R&D: IQVIA

6/4/2025Driving Business Growth Through Investment Funds: Analyses and Practic...

6/4/2025Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...

6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/20252025 Outlook for Medtech in China (Simon Kucher)

5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Recent Official and Executive Moves

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

Page:1/359 Total number of articles:10741: [First][<<] [1] [2] [3] [4] [5] [>>] [End]